Medications That Cause Insomnia: A Complete Guide

Why Medications Cause Insomnia

Medications don't disrupt sleep through a single mechanism. Depending on the drug class, one or more of the following pathways may be at work.

• Stimulant effect. Drugs like bupropion, pseudoephedrine, and thyroid hormone activate the central nervous system, increasing arousal. When the sympathetic nervous system is excited, the brain struggles to shift into sleep mode.
• Serotonin disruption. SSRIs increase serotonin levels. Serotonin promotes wakefulness during the day and serves as a precursor to melatonin at night. In the early weeks, this imbalance can produce insomnia before the system re-equilibrates.
• Cortisol elevation. Corticosteroids like prednisone directly activate cortisol pathways. Elevated nighttime cortisol suppresses melatonin and keeps the body in an alert, ready-to-wake state.
• Melatonin suppression. Beta-blockers block the beta-adrenergic receptors required for melatonin synthesis. Research shows that lipophilic beta-blockers like propranolol can reduce nocturnal melatonin secretion by up to 80%. (Stoschitzky et al., 1999)
• GI-mediated arousals. Some drugs disrupt sleep indirectly by causing gastrointestinal symptoms — nausea, acid reflux, abdominal discomfort — that wake you up. GLP-1 drugs are a prime example.

GLP-1 Medications and Sleep: Zepbound and Wegovy

Tirzepatide (Zepbound) and semaglutide (Wegovy, Ozempic) are among the most prescribed weight management and diabetes medications today. The FDA prescribing information for Zepbound lists insomnia as an adverse reaction. (FDA, Zepbound Prescribing Information, 2025)

In clinical trials, the most commonly reported adverse reactions were gastrointestinal: nausea (12–29% depending on dose), diarrhea (12–16%), vomiting (5–9%), constipation, and abdominal pain. These symptoms — especially during dose escalation — are the primary mechanism behind sleep disruption.

A real-world social media analysis (PMC10669484) found GLP-1 users reported sleep issues — including over 620 mentions of insomnia — at rates higher than expected from clinical trials alone. The dominant mechanism appears to be GI side effects rather than direct central nervous system action.

Long term, weight loss and metabolic improvement from GLP-1 drugs may actually improve sleep quality, including reducing sleep apnea severity. Getting through the initial adjustment period matters.

SSRIs and Sleep: Lexapro (Escitalopram)

SSRIs including escitalopram (Lexapro) list insomnia as a documented adverse reaction. According to FDA prescribing information, insomnia was reported in 9% of Lexapro patients vs. 4% placebo in major depressive disorder trials, and 12% vs. 6% placebo in generalized anxiety disorder trials. (FDA, Lexapro Prescribing Information, 2017)

Dose dependence is clear: at 20 mg/day, the incidence of insomnia and several other side effects was approximately twice that of the 10 mg/day group.

There is good news. Research published on PubMed (PMID: 22057726) confirms that SSRI-induced insomnia is typically most pronounced in the first 2–4 weeks, then naturally improves. During this window, optimizing sleep hygiene and communicating with your doctor if symptoms persist is the key strategy.

Bupropion (Wellbutrin) and Sleep

Bupropion (Wellbutrin) is a norepinephrine-dopamine reuptake inhibitor (NDRI) with a distinctly stimulating profile unlike other antidepressants. Per FDA prescribing information, insomnia occurred in 11% of patients on Wellbutrin SR 300 mg/day vs. 6% placebo, rising to 16% at 400 mg/day. (FDA, Wellbutrin SR Prescribing Information, 2025)

The primary mitigation is timing. FDA prescribing information advises that if insomnia occurs, doses should not be taken too close to bedtime. Morning dosing of the XL formulation results in lower drug levels during evening hours, which may reduce insomnia risk.

Research published in the Journal of Psychiatric Practice (2003) demonstrated that formulation matters: the XL formulation taken in the morning showed the most favorable insomnia profile compared to IR and SR formulations.

Other Common Insomnia-Causing Medications

Several other drug classes are well-documented to disrupt sleep:

• Beta-blockers (propranolol, metoprolol, etc.) — Lipophilic beta-blockers cross the blood-brain barrier and reduce nocturnal melatonin secretion by up to 80%. Insomnia, vivid dreams, and nighttime awakenings are common. (Stoschitzky et al., Eur J Clin Pharmacol, 1999) Water-soluble alternatives like atenolol or bisoprolol are significantly less disruptive to sleep.
• Corticosteroids (prednisone, etc.) — Directly activates cortisol pathways, keeping the body in an energized, alert state. Taking the full dose in the morning significantly reduces this effect. For more on how cortisol affects sleep, see our cortisol and sleep guide.
• Decongestants (pseudoephedrine, Sudafed) — A sympathomimetic stimulant that increases heart rate and alertness. Insomnia is likely with evening use. Restricting dosing to morning hours and avoiding evening use is the standard clinical advice.
• Thyroid hormone (levothyroxine) — If the dose is too high or taken too late in the day, it can produce hyperthyroid-like symptoms including anxiety, insomnia, and palpitations. This is particularly common when starting the medication or adjusting doses.
• ADHD medications (amphetamines, methylphenidate) — Potent dopamine-norepinephrine stimulants that increase sleep latency and reduce deep sleep. Dose timing management is the primary strategy.

What to Do If Your Medication Causes Insomnia

The first and most important rule: do not stop a prescription medication on your own. In most cases, there are better solutions.

1. Tell your doctor. Keep track of when you started or changed a medication and when sleep problems began. Temporal correlation is critical information for your doctor to identify the cause.
2. Ask about timing adjustments. Stimulating medications (Wellbutrin, thyroid hormone, ADHD drugs) should generally be taken as early in the morning as possible. Corticosteroids should be consolidated into morning dosing.
3. Optimize your sleep hygiene. Optimizing sleep hygiene acts as a buffer against medication-related disruptions. Consistent sleep-wake timing, a cool bedroom, and limiting screen exposure before bed are especially important. See our full sleep hygiene checklist.
4. Consider CBT-I. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment recommended by the American Academy of Sleep Medicine (AASM) above sleeping pills, and it is effective even when medications are a contributing factor.
5. Discuss melatonin supplementation. If you take beta-blockers, ask your doctor about low-dose melatonin. A randomized controlled trial found that 2.5 mg of nightly melatonin for 3 weeks significantly improved sleep quality in hypertensive patients on beta-blockers without rebound. (Scheer et al., Sleep, 2012) See our melatonin guide for dosing details.
6. Track your sleep patterns. Tracking your sleep from the day you start a medication gives you objective data on its effect — valuable evidence for your doctor conversations. For techniques to use on nights you can't sleep, see this guide.

Medical Disclaimer